Pharmacokinetics of bendroflumethiazide
- 1 October 1977
- journal article
- research article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 22 (4) , 385-388
- https://doi.org/10.1002/cpt1977224385
Abstract
Bendrojlumethiazide (bft) , 10 mg, was administered orally to 9 healthy volunteers. The concentrations of the diuretic in plasma and urine were determined by gas‐liquid chromatography (GLC). Peak plasma levels (86 ± 18 ng/ml) of bft were reached at 2 ± 0.4 hr. The concentration declined with a mean tlh of 3.0 hr. The apparent volume of distribution averaged 1.48 Llkg. The major part of the drug was eliminated via nonrenal mechanisms, the nonrenal clearance being estimated to 269 ± 77 mllmin and renal clearance to 105 ± 24 mllmin. Urinary recovery of the thiazide averaged 30%.This publication has 5 references indexed in Scilit:
- Absorption, metabolism, and excretion of hydrochlorothiazideClinical Pharmacology & Therapeutics, 1976
- A GLC assay for bendroflumethiazide. Preliminary data about its plasma level in manEuropean Journal of Clinical Pharmacology, 1976
- S35-Labeled Bendroflumethiazide in Human BeingsArchives of internal medicine (1960), 1964
- PHARMACOLOGY OF BENZYDROFLUMETHIAZIDE (NATURETIN)1961
- Pharmacologic observations on a more potent benzothiadiazine diuretic (Be. 724-A)American Heart Journal, 1960